Novel 3-hydroxy-5-arylisothiazole derivative

Details for Australian Patent Application No. 2010336225 (hide)

Owner Mochida Pharmaceutical Co.,Ltd.

Inventors Okano, Akihiro; Kosuga, Naoto; Ohkouchi, Munetaka; Hotta, Daido; Makabe, Muneyoshi

Agent Spruson & Ferguson

Pub. Number AU-A-2010336225

PCT Pub. Number WO2011/078371

Priority 2009-295855 25.12.09 JP; 2010-043420 26.02.10 JP

Filing date 24 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 275/02 Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

A61P 3/10 Drugs for disorders of the metabolism

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 - Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/4439

A61K 31/506 - not condensed and containing further heterocyclic rings

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/078371 Priority application(s): WO2011/078371

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010336248-Aminopyridine compound

2010336217-Mobile communication method and exchange station